These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 15788897)
1. Transfection protocol for antisense oligonucleotides affects uniformity of transfection in cell culture and efficiency of mRNA target reduction. Reed CA; Peralta ER; Wenrich LM; Wong CA; Bennett CF; Freier S; Lollo B Oligonucleotides; 2005; 15(1):12-22. PubMed ID: 15788897 [TBL] [Abstract][Full Text] [Related]
2. Characterization of interaction between cationic lipid-oligonucleotide complexes and cellular membrane lipids using confocal imaging and fluorescence correlation spectroscopy. Gordon SP; Berezhna S; Scherfeld D; Kahya N; Schwille P Biophys J; 2005 Jan; 88(1):305-16. PubMed ID: 15516528 [TBL] [Abstract][Full Text] [Related]
3. Development of efficient transient transfection systems for introducing antisense oligonucleotides into human epithelial skin cells. Fimmel S; Saborowski A; Orfanos CE; Zouboulis CC Horm Res; 2000; 54(5-6):306-11. PubMed ID: 11595823 [TBL] [Abstract][Full Text] [Related]
4. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. Griesenbach U; Kitson C; Escudero Garcia S; Farley R; Singh C; Somerton L; Painter H; Smith RL; Gill DR; Hyde SC; Chow YH; Hu J; Gray M; Edbrooke M; Ogilvie V; MacGregor G; Scheule RK; Cheng SH; Caplen NJ; Alton EW Respir Res; 2006 Feb; 7(1):26. PubMed ID: 16480492 [TBL] [Abstract][Full Text] [Related]
5. Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes. Hartmann G; Krug A; Bidlingmaier M; Hacker U; Eigler A; Albrecht R; Strasburger CJ; Endres S J Pharmacol Exp Ther; 1998 May; 285(2):920-8. PubMed ID: 9580645 [TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides. Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801 [TBL] [Abstract][Full Text] [Related]
8. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis. Buck AC; Shen C; Schirrmeister H; Schmid-Kotsas A; Munzert G; Guhlmann A; Mehrke G; Klug N; Gross HJ; Bachem M; Reske SN Cancer Biother Radiopharm; 2002 Jun; 17(3):281-9. PubMed ID: 12136520 [TBL] [Abstract][Full Text] [Related]
9. Cationic lipid-protamine-DNA (LPD) complexes for delivery of antisense c-myc oligonucleotides. Junghans M; Loitsch SM; Steiniger SC; Kreuter J; Zimmer A Eur J Pharm Biopharm; 2005 Jul; 60(2):287-94. PubMed ID: 15939239 [TBL] [Abstract][Full Text] [Related]
10. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549]. Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540 [TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of antisense oligonucleotide of integrin-linked kinase on cell proliferation of human epithelial ovarian cancer]. Li Q; Zhang YH; Li PL; Pei JR Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):218-22. PubMed ID: 18788574 [TBL] [Abstract][Full Text] [Related]
12. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides. Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777 [TBL] [Abstract][Full Text] [Related]
13. Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-kappaB into activated macrophages. De Rosa G; De Stefano D; Laguardia V; Arpicco S; Simeon V; Carnuccio R; Fattal E Eur J Pharm Biopharm; 2008 Sep; 70(1):7-18. PubMed ID: 18482831 [TBL] [Abstract][Full Text] [Related]
14. Structure-transfection activity relationships in a series of novel cationic lipids with heterocyclic head-groups. Ivanova EA; Maslov MA; Kabilova TO; Puchkov PA; Alekseeva AS; Boldyrev IA; Vlassov VV; Serebrennikova GA; Morozova NG; Zenkova MA Org Biomol Chem; 2013 Nov; 11(41):7164-78. PubMed ID: 24057052 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids. Arpicco S; Canevari S; Ceruti M; Galmozzi E; Rocco F; Cattel L Farmaco; 2004 Nov; 59(11):869-78. PubMed ID: 15544791 [TBL] [Abstract][Full Text] [Related]
16. Cationic vesicles based on non-ionic surfactant and synthetic aminolipids mediate delivery of antisense oligonucleotides into mammalian cells. Grijalvo S; Alagia A; Puras G; Zárate J; Pedraz JL; Eritja R Colloids Surf B Biointerfaces; 2014 Jul; 119():30-7. PubMed ID: 24859051 [TBL] [Abstract][Full Text] [Related]
17. [Study on the antisense inhibition effect of liposome-mediated radiolabled antisense oligonucleotides of c-myc mRNA]. Zheng J; Tan T; Pan W; Zhang C Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):413-6. PubMed ID: 12910676 [TBL] [Abstract][Full Text] [Related]
18. Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA. Ittig D; Liu S; Renneberg D; Schümperli D; Leumann CJ Nucleic Acids Res; 2004; 32(1):346-53. PubMed ID: 14726483 [TBL] [Abstract][Full Text] [Related]
19. [Inducing apoptosis of HeLa cell lines by transfection of c-myc antisense oligonucleotides]. Li RR; Ma DX; Cheng YF Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):19-22. PubMed ID: 16468633 [TBL] [Abstract][Full Text] [Related]
20. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Lewis JG; Lin KY; Kothavale A; Flanagan WM; Matteucci MD; DePrince RB; Mook RA; Hendren RW; Wagner RW Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3176-81. PubMed ID: 8622909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]